SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.45 CNY | +0.88% |
|
+0.05% | -15.69% |
| 2023 | Yiling Pharmaceutical Gets Nod for China Clinical Trial of Tracheobronchitis Drug | MT |
| 2023 | Yiling Pharmaceutical's Lianhua Qingke Tablets Gets Nod to Become Over-the-Counter Drug; Shares Up 4% | MT |
| Sales 2023 * | 11.2B 1.55B | Sales 2024 * | 12.97B 1.79B | Capitalization | 32.5B 4.49B |
|---|---|---|---|---|---|
| Net income 2023 * | 2.1B 290M | Net income 2024 * | 2.46B 340M | EV / Sales 2023 * | 2.8 x |
| Net cash position 2023 * | 1.2B 165M | Net cash position 2024 * | 2.35B 324M | EV / Sales 2024 * | 2.32 x |
| P/E ratio 2023 * |
15.5
x | P/E ratio 2024 * |
13.2
x | Employees | 15,074 |
| Yield 2023 * |
2.45% | Yield 2024 * |
2.57% | Free-Float | 41.69% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.88% | ||
| 1 week | +0.05% | ||
| Current month | -3.57% | ||
| 1 month | -4.70% | ||
| 3 months | -12.74% | ||
| 6 months | -10.20% | ||
| Current year | -15.69% |
1 week
18.95
19.60
1 month
18.9520.56
Current year
17.8024.47
1 year
17.8033.29
3 years
15.3853.96
5 years
7.1553.96
10 years
7.0853.96
| Managers | Title | Age | Since |
|---|---|---|---|
Xiang Jun Wu
CEO | Chief Executive Officer | 49 | 04-12-31 |
Chen Guang Li
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Qiu Lian Zhang
BRD | Director/Board Member | 54 | 15-03-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Ling Wu
FOU | Founder | 75 | 01-08-27 |
Xiang Jun Wu
CEO | Chief Executive Officer | 49 | 04-12-31 |
Chen Guang Li
DFI | Director of Finance/CFO | 51 | 96-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.90% | 2 M€ | -18.13% | - | |
| 0.66% | 4 M€ | -2.96% | ||
| 0.57% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 19.45 | +0.88% | 11,485,320 |
| 24-04-24 | 19.28 | -0.46% | 7,092,839 |
| 24-04-23 | 19.37 | +0.52% | 11,331,790 |
| 24-04-22 | 19.27 | -0.21% | 10,261,370 |
| 24-04-19 | 19.31 | -0.67% | 7,820,811 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company mainly provides cardiovascular and cerebrovascular drugs and anti-cold drugs. The Company also provides food and beverage products. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
19.45
CNY
Average target price
27.02
CNY
Spread / Average Target
+38.94%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.69% | 4.49B | |
| +37.37% | 6.02B | |
| -12.46% | 3.06B | |
| -0.12% | 3.04B | |
| +0.47% | 2.61B | |
| +36.06% | 1.81B | |
| +0.84% | 1.66B | |
| -10.60% | 1.63B | |
| -12.03% | 1.55B | |
| +36.40% | 1.41B |
- Stock Market
- Equities
- 002603 Stock
